In January, Barrow Neurological Institute became the first center to surgically implant a new deep brain stimulation (DBS) system by Boston Scientific. Dr. Francisco Ponce, director of the DBS Program at Barrow, performed the procedure.

The medical device manufacturer designed the Vercise Directional DBS Systems to allow physicians to control the range, shape, position, and direction of electrical stimulation to treat symptoms of Parkinson’s disease.

“These factors may improve patient comfort and allow physicians to adjust treatment as a patient’s needs change,” Dr. Ponce said.

Read the press release: Boston Scientific Launches Vercise Primary Cell and Vercise Gevia Deep Brain Stimulation Systems with Directional Leads